Literature DB >> 8494842

Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp.

A H Ugwumadu1, D Bower, P K Ho.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494842     DOI: 10.1111/j.1471-0528.1993.tb12986.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


× No keyword cloud information.
  7 in total

Review 1.  Tamoxifen and secondary tumours. An update.

Authors:  N Wilking; E Isaksson; E von Schoultz
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 2.  What do we know and what don't we know about tamoxifen in the human uterus.

Authors:  A Friedl; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  Abnormal vaginal bleeding from endometrial polyps in a woman receiving tamoxifen therapy for breast cancer: report of a case.

Authors:  T Fujikawa; S Nishimura; S Matsusue; H Takeda
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

Review 4.  The Potential Relationship Between Environmental Endocrine Disruptor Exposure and the Development of Endometriosis and Adenomyosis.

Authors:  Victoria R Stephens; Jelonia T Rumph; Sharareh Ameli; Kaylon L Bruner-Tran; Kevin G Osteen
Journal:  Front Physiol       Date:  2022-01-28       Impact factor: 4.566

Review 5.  The effect of tamoxifen on the genital tract.

Authors:  Sandra A Polin; Susan M Ascher
Journal:  Cancer Imaging       Date:  2008-06-30       Impact factor: 3.909

6.  Proteomic Analysis of Uterine Tissues During Peri-Implantation Period in Mice with Experimentally Induced Adenomyosis that Treated with anti-Ngf: Implications for Cell-Cell Adhesion and Metabolic Processes.

Authors:  Yan Li; Dan Zhang; Bailing Jin; Lan Xia; Aijun Zhang
Journal:  Reprod Sci       Date:  2020-07-16       Impact factor: 3.060

Review 7.  Adenomyosis pathogenesis: insights from next-generation sequencing.

Authors:  Serdar E Bulun; Sule Yildiz; Mazhar Adli; Jian-Jun Wei
Journal:  Hum Reprod Update       Date:  2021-10-18       Impact factor: 15.610

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.